Clinical Trial Update: Study to Find Maintenance Dose for Periodic Administration of ASP3550 [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a maintenance dose for periodic administration of ASP3550 in prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ASP3550

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED